Intraneuronal dopamine-quinone synthesis: a review

Sulzer, David, Zecca, Luigi·1999·Neurotoxicity Research
DOI 10.1007/bf03033289

Cited by (282)

Items 101–200 of 282

  1. Increased Vesicular Monoamine Transporter 2 (VMAT2;Slc18a2) Protects against Methamphetamine Toxicity
    Kelly M. Lohr, Kristen A. Stout, Amy R. Dunn, Minzheng Wang, Ali Salahpour, Thomas S. Guillot, Gary Wright Miller · 2015 · ACS Chemical Neuroscience
  2. Changes in Neuronal Dopamine Homeostasis following 1-Methyl-4-phenylpyridinium (MPP+) Exposure
    Se Joon Choi, Anne E. Panhelainen, Yvonne Schmitz, Kristin E. Larsen, Ellen Kanter, Min Wu, David Sulzer, Eugene V. Mosharov · 2015 · Journal of Biological Chemistry
  3. Quinone Reductase 2 Is a Catechol Quinone Reductase
    Yue Fu, Leonid Buryanovskyy, Zhongtao Zhang · 2008 · Journal of Biological Chemistry
  4. Determination of dopamine in presence of ascorbic acid and uric acid using poly (Spands Reagent) modified carbon paste electrode
    Yenugu Veera Manohara Reddy, V. Prabhakara Rao, Ambavaram Vijaya Bhaskar Reddy, Mallu Lavanya, Manthrapudi Venu, Mallu Lavanya, Gajulapalle Madhavi · 2015 · Materials Science and Engineering C
  5. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity
    Thomas S. Guillot, Jason R. Richardson, M.Z. Wang, Y.J. Li, T.N. Taylor, B.J. Ciliax, Olof Zachrisson, A. Mercer, Gary Wright Miller · 2008 · Neuropeptides
  6. Pitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity
    Eduardo Coelho Cerqueira, Anderson S. Pinheiro, Cristian Follmer · 2014 · Bioorganic & Medicinal Chemistry Letters
  7. Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson’s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis
    Se Jin Cho, Yun Jung Bae, Jong‐Min Kim, Donghyun Kim, Sung Hyun Baik, Leonard Sunwoo, Byung Se Choi, Jae Hyoung Kim · 2020 · European Radiology
  8. DJ-1 Protects Against Dopamine Toxicity: Implications for Parkinson's Disease and Aging
    Nirit Lev, Yael Barhum, N. S. Pilosof, Diana E. Ickowicz, Haim Yosef Cohen, Eldad Melamed, Daniel Offen · 2012 · The Journals of Gerontology Series A
  9. Synergistic Neurotoxic Effects of Arsenic and Dopamine in Human Dopaminergic Neuroblastoma SH-SY5Y Cells
    Shavali Shaik, Donald A. Sens · 2007 · Toxicological Sciences
  10. VMAT2 and Parkinson’s disease: harnessing the dopamine vesicle
    Kelly M. Lohr, Gary Wright Miller · 2014 · Expert Review of Neurotherapeutics
  11. Translational molecular imaging and drug development in Parkinson’s disease
    Ahmed Haider, Nehal H. Elghazawy, Alyaa Dawoud, Cathérine Gebhard, Thomas Wichmann, Wolfgang Sippl, Marius Christian Hoener, Ernest Arenas, Steven H. Liang · 2023 · Molecular Neurodegeneration
  12. Biosynthetic pathway to neuromelanin and its aging process
    Kazumasa Wakamatsu, Takaya Murase, Fabio Andrea Zucca, Luigi Zecca, Shosuke Ito · 2012 · Pigment Cell & Melanoma Research
  13. Neuroinflammation Mechanisms and Phytotherapeutic Intervention: A Systematic Review
    Navrinder Kaur, Heerak Chugh, Meena Kishore Sakharkar, Uma Dhawan, Saravana Babu Chidambaram, Ramesh Chandra · 2020 · ACS Chemical Neuroscience
  14. Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death
    Åsa Petersén, K.E. Larsen, Gerald G Behr, N. Romero, Serge Przedborski, Patrik Brundin, David L. Sulzer · 2001 · Brain Research Bulletin
  15. Interactions of HIV and Drugs of Abuse
    Kurt F. Hauser, Pamela E. Knapp · 2014 · International review of neurobiology
  16. Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone
    Lucyna Antkiewicz‐Michaluk, Jadwiga Wardas, Jerzy Michaluk, Irena Romańska, Andrzej Jacek Bojarski, Jerzy Vetulani · 2004 · The International Journal of Neuropsychopharmacology
  17. Multifunctional and High Affinity Polymer Ligand that Provides Bio-Orthogonal Coating of Quantum Dots
    Wentao Wang, Anshika Kapur, Xin Ji, Birong Zeng, Dinesh Mishra, Hedi M. Mattoussi · 2016 · Bioconjugate Chemistry
  18. Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology
    Stefania Romeo, Cristina Viaggi, Daniela Di Camillo, Allison Wright Willis, L. Lozzi, Cristina Rocchi, Marta Capannolo, Gabriella Aloisi, Francesca Vaglini, Rita Maccarone et al. · 2013 · Scientific Reports
  19. Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats
    Ghada A. Badawi, Mai A. Abd El Fattah, Hala Fahmy Zaki, Moushira I. El Sayed · 2019 · Neurotoxicity Research
  20. Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
    Augusta Pisanu, Laura Boi, Giovanna Mulas, Saturnino Spiga, Sandro Fenu, Anna Rosa Carta · 2018 · Journal of Neural Transmission
  21. Exploring optoelectronic properties of undoped and amine-doped carbon dots: Impact of surface functionalization and pH
    Aradhana Panigrahi, Ranjan Kumar Behera, Leepsa Mishra, Satish Kumar, Priyanka Dubey, Soumi Dutta, Manas Kumar Sarangi · 2023 · Carbon
  22. Vesicular Integrity in Parkinson’s Disease
    Shawn P. Alter, Gina M. Lenzi, Alison I. Bernstein, Gary Wright Miller · 2013 · Current Neurology and Neuroscience Reports
  23. Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals
    Kelly M. Lohr, Merry Chen, Carlie A. Hoffman, Miranda J. McDaniel, Kristen A. Stout, Amy R. Dunn, Minzheng Wang, Alison I. Bernstein, Gary Wright Miller · 2016 · Toxicological Sciences
  24. Thioredoxin Suppresses Parkin-associated Endothelin Receptor-like Receptor-induced Neurotoxicity and Extends Longevity in Drosophila
    Yumi Umeda‐Kameyama, Manabu Tsuda, Chiaki Ohkura, Takashi Matsuo, Yoshio Namba, Yasuyoshi Ohuchi, Toshiro Aigaki · 2007 · Journal of Biological Chemistry
  25. Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model
    Pol Giménez‐Xavier, Roser Francisco, Antonio F. Santidrián, Joan Gil, Santiago Ambrosio · 2009 · NeuroToxicology
  26. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation
    Masato Asanuma, Ikuko Miyazaki, Francisco J. Javier Diaz-Corrales, Ko Miyoshi, Norio Ogawa, Miho Murata · 2007 · Neuroscience Research
  27. Hydroxytyrosol induces phase II detoxifying enzyme expression and effectively protects dopaminergic cells against dopamine- and 6-hydroxydopamine induced cytotoxicity
    Guohua Yu, Ajun Deng, Wanbin Tang, MA Junzhi, Chonggang Yuan, Jiyan Ma · 2016 · Neurochemistry International
  28. Catecholamines up integrates dopamine synthesis and synaptic trafficking
    Zhe Wang, Faiza Ferdousy, Hakeem O. Lawal, Zhinong Huang, J. Gavin Daigle, Iyare Izevbaye, Olugbenga M. Doherty, Jerrad Thomas, Dean G. Stathakis, Janis M. O’Donnell · 2011 · Journal of Neurochemistry
  29. Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6‐hydroxydopamine
    Åsa Petersén, Oskar Hansson, Zoe Puschban, Ellen Sapp, Norma B. Romero, Roger Frigerio Castilho, David L. Sulzer, Margaret E. Rice, Marian DiFiglia, Serge Przedborski et al. · 2001 · European Journal of Neuroscience
  30. Inhibition of the Fe(III)-Catalyzed Dopamine Oxidation by ATP and Its Relevance to Oxidative Stress in Parkinson’s Disease
    Dianlu Jiang, Shuyun Shi, Lin Zhang, Lin Liu, Bingrong Ding, Bingqing Zhao, Gargey B. Yagnik, Feimeng Zhou · 2013 · ACS Chemical Neuroscience
  31. Mic60/mitofilin overexpression alters mitochondrial dynamics and attenuates vulnerability of dopaminergic cells to dopamine and rotenone
    Victor S. Van Laar, Sarah B. Berman, Teresa G. Hastings · 2016 · Neurobiology of Disease
  32. Neuromelanin in Parkinson’s Disease: from Fenton Reaction to Calcium Signaling
    Rainer Knörle · 2017 · Neurotoxicity Research
  33. Dopamine and norepinephrine are embracing their immune side and so should we
    Peter J. Gaskill, Habibeh Khoshbouei · 2022 · Current Opinion in Neurobiology
  34. Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
    Kathleen Carmichael, Breanna T Sullivan, Elena Lopez, Lixin Sun, Huaibin Cai · 2021 · Ageing and Neurodegenerative Diseases
  35. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation
    Donna Seger · 2010 · Clinical Toxicology
  36. Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
    Steven M. Graves, Sarah E. Schwarzschild, Rex Tai, Yu Chen, Dalton James Surmeier · 2021 · Neurobiology of Disease
  37. Inflammation in parkinson’s disease
    Andreas Hald, Johan van Beek, Julie Lotharius · 2007 · Sub-cellular biochemistry/Subcellular biochemistry
  38. L-DOPA treatment from the viewpoint of neuroprotection
    Norio Ogawa, Masato Asanuma, Ikuko Miyazaki, Francisco J. Javier Diaz-Corrales, Ko Miyoshi · 2005 · Journal of Neurology
  39. 5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease
    Isidro Badillo‐Ramírez, José Manuel Saniger, Selva Rivas-Arancibia · 2019 · Neurochemistry International
  40. Autophagy as a gateway for the effects of methamphetamine: From neurotransmitter release and synaptic plasticity to psychiatric and neurodegenerative disorders
    Fiona Limanaqi, Carla Letizia Busceti, Roberta Celli, Francesca Biagioni, Francesco Fornai · 2021 · Progress in Neurobiology
  41. The Pigment in Alkaptonuria Relationship to Melanin and Other Coloured Substances: A Review of Metabolism, Composition and Chemical Analysis
    N B Roberts, S. A. Curtis, Anna M. Milan, Lakshminarayan R Ranganath · 2015 · JIMD Reports
  42. Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-d-aspartate currents in rat substantia nigra dopamine neurons
    Yan Wu, Steven W. Johnson · 2011 · Neuroscience
  43. Effects of 1,4-butanediol administration on oxidative stress in rat brain: Study of the neurotoxicity of γ-hydroxybutyric acid in vivo
    Ângela Malysz Sgaravatti, Alessandra Selinger Magnusson, Amanda Szekir de Oliveira, Caroline Paula Mescka, Fernanda Rech Zanin, M Sgarbi, Carolina Didonet Pederzolli, Ângela Terezinha de Souza Wyse, Clóvis Milton Duval Wannmacher, Moaçir Wajner et al. · 2009 · Metabolic Brain Disease
  44. Oxidation properties of dopamine at and near physiological conditions
    Jaroslav Vatrál, Roman Boča, Wolfgang Linert · 2015 · Monatshefte für Chemie - Chemical Monthly
  45. Reactive oxygen species production and MAPK activation are implicated in tetrahydrobiopterin-induced SH-SY5Y cell death
    Vasutakarn Chongthammakun, Yupin Sanvarinda, Sukumal Chongthammakun · 2008 · Neuroscience Letters
  46. Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase‐deficient mice
    Alexandra Latini, Karina Scussiato, Guilhian Leipnitz, K. Michael Gibson, Moaçir Wajner · 2007 · Journal of Inherited Metabolic Disease
  47. Novel poly(vinyl alcohol) nanofiltration membrane modified with dopamine coated anatase TiO2 core shell nanoparticles
    Faiz Khalid, M. Tabish, Kainat Amin Bora · 2020 · Journal of Water Process Engineering
  48. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain
    Rachel A. Cliburn, Amy R. Dunn, Kristen A. Stout, Carlie A. Hoffman, Kelly M. Lohr, Alison I. Bernstein, Emily J. Winokur, James P. Burkett, Yvonne Schmitz, William Michael Caudle et al. · 2016 · Journal of Chemical Neuroanatomy
  49. Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells
    Jie Li, Carsten Scheller, Eleni Koutsilieri, Francine Carew‐Jones, Philip M. Beart, Linda D. Mercer, Glenda Margaret Halliday, Emma Kettle, Dominic B. Rowe, Peter Franz Riederer et al. · 2005 · Journal of Neurochemistry
  50. Plant Polyphenols as Neuroprotective Agents in Parkinson’s Disease Targeting Oxidative Stress
    Suet Lee Hor, Seong Lin Teoh, Wei Ling Lim · 2019 · Current Drug Targets
  51. Dopamine Selectively Sensitizes Dopaminergic Neurons to Rotenone-Induced Apoptosis
    Ferogh A. Ahmadi, Tom N. Grammatopoulos, Andy M. Poczobutt, Susan M. Jones, Laurence D. Snell, Mita Das, W. Michael Zawada · 2007 · Neurochemical Research
  52. Poly (sunset yellow) sensor for dopamine: A voltammetric study
    Chethan M. Kuskur, Bahaddurghatta E. Kumara Swamy, K. Shivakumar, Hanasavadi Parameshwarappa Jayadevappa, Saurabh Sharma · 2019 · Journal of Electroanalytical Chemistry
  53. Adult and in utero exposure to cocaine alters sensitivity to the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    S.A. Lloyd, Ciaran J. Faherty, Richard Jay Smeyne · 2005 · Neuroscience
  54. In vitro anticholinesterase, antimonoamine oxidase and antioxidant properties of alkaloid extracts from kola nuts ( Cola acuminata and Cola nitida )
    Ganiyu Oboh, Ayokunle Olubode Ademosun, Opeyemi Babatunde Ogunsuyi, Esther T. Oyedola, Tosin Abiola Olasehinde, Sunday I. Oyeleye · 2018 · Journal of Complementary and Integrative Medicine
  55. Review on apoptosis vs. necrosis of substantia nigrapars compacta in parkinson’s disease
    Richard M. Kostrzewa · 2000 · Neurotoxicity Research
  56. Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum
    Richard M. Kostrzewa, John P. Kostrzewa, R Brus · 2000 · Amino Acids
  57. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra
    Shoji Yamamoto, Jiro Fukae, Hideo Mori, Yoshikuni Mizuno, Nobutaka Hattori · 2005 · Neuroscience Letters
  58. Quinoprotein Adducts Accumulate in the Substantia Nigra of Aged Rats and Correlate with Dopamine-Induced Toxicity in SH-SY5Y Cells
    Na Wang, Yan Wang, Guohua Yu, Chonggang Yuan, Jiyan Ma · 2011 · Neurochemical Research
  59. Neuronal signaling repertoire in the mammalian sperm functionality
    Alfredo Ramírez‐Reveco, Franz Villarroel‐Espíndola, Joan Enric Rodríguez-Gil, Ilona I. Concha · 2017 · Biology of Reproduction
  60. Methamphetamine Administration Reduces Hippocampal Vesicular Monoamine Transporter-2 Uptake
    Kristi S. Rau, Elisabeth Birdsall, Trent J. Volz, James A. Riordan, Anthony J. Baucum, Brian P. Adair, Rebecca Bitter, James W. Gibb, Glen R. Hanson, Annette E. Fleckenstein · 2006 · Journal of Pharmacology and Experimental Therapeutics
  61. Nonsteroidal anti-inflammatory drugs in Parkinson’s disease: possible involvement of quinone formation
    M. Asanuma, Ikuko Miyazaki · 2006 · Expert Review of Neurotherapeutics
  62. In vivo protein targets for increased quinoprotein adduct formation in aged substantia nigra
    Guohua Yu, Huiyan Liu, Wei Ping Zhou, Xuewei Zhu, Chao Yuan Yu, Na Wang, Yi Zhang, Ji Ma, Yulan Zhao, Yuanyuan Xu et al. · 2015 · Experimental Neurology
  63. Screening of Therapeutic Strategies for Huntington's Disease in YAC128 Transgenic Mice
    Joana Gil‐Mohapel · 2011 · CNS Neuroscience & Therapeutics
  64. The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
    Lena F. Burbulla, Dimitri Krainc · 2019 · Neurobiology of Disease
  65. An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
    Qiang Liu, Pan Wang, Chenghe Liu, Feng Xue, Qian Wang, Yuqing Chen, Ruihua H. Hou, Teng Chen · 2023 · BMC Neurology
  66. Antioxidative protection of haemoglobin microparticles (HbMPs) by PolyDopamine
    Olga Baidukova, Quan Wang, Saranya Chaiwaree, Dorette Freyer, Ausanai Prapan, Radostina T. Georgieva, Lian Zhao, Hans Bäumler · 2018 · Artificial Cells Nanomedicine and Biotechnology
  67. The Oxidative Pathway to Dopamine–Protein Conjugates and Their Pro-Oxidant Activities: Implications for the Neurodegeneration of Parkinson’s Disease
    Kazumasa Wakamatsu, Kenta Nakao, Hitomi Tanaka, Yuki Kitahori, Yui Tanaka, Makoto Ojika, Shosuke Ito · 2019 · International Journal of Molecular Sciences
  68. Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms
    Mary Dayne S. Tai, Gloria Gamiz-Arco, Aurora Martı́nez · 2024 · Biochemical Society Transactions
  69. “Reframing” dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications
    Bianca Marchetti, Carmela Giachino, Cataldo Tirolo, Maria Francesca Serapide · 2022 · Aging Cell
  70. Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes
    Maximilian Wulf, Katalin Barkovits, Karin Schork, Martin Eisenacher, Peter Franz Riederer, Manfred Gerlach, Britta Eggers, Katrin Marcus · 2022 · Journal of Neural Transmission
  71. RETRACTED ARTICLE: Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression
    Kenneth Wengler, Brandon K. Ashinoff, Elena Pueraro, Clifford Cassidy, Guillermo Horga, Bret R. Rutherford · 2020 · Neuropsychopharmacology · Retracted
  72. The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
    Danielle E. Mor, Harry Ischiropoulos · 2018 · Journal of Experimental Neuroscience
  73. Adverse outcome pathways induced by 3,4-dimethylmethcathinone and 4-methylmethcathinone in differentiated human SH-SY5Y neuronal cells
    Jorge Soares, Vera Marisa Costa, Helena Gaspar, Susana Santos, Maria de Lourdes Bastos, Félix Dias Carvalho, João Paulo Capela · 2020 · Archives of Toxicology
  74. Peroxidase-mediated oxidation of l-dopa: A kinetic approach
    Mihaela Puiu, Irina Babaligea, Cătalina Olmazu, Adina Răducan, Dumitru Oancea · 2010 · Biochemical Engineering Journal
  75. The effect of antiparkinsonian drugs on oxidative stress induced pathological [3H]dopamine efflux after in vitro rotenone exposure in rat striatal slices
    Elisaveta Milusheva, Mária Baranyi, Eszter Kormos, Zsuzsanna Hracskó, E. Sylvester Vizi, Beáta Sperlágh · 2009 · Neuropharmacology
  76. Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy
    Cristian Follmer · 2014 · Expert Review of Neurotherapeutics
  77. Tetrabenazine for treatment of chorea associated with Huntington's disease and other potential indications
    Joohi Jimenez Shahed, Joseph J. Jankovic · 2013 · Expert Opinion on Orphan Drugs
  78. Insulin and Exendin-4 Reduced Mutated Huntingtin Accumulation in Neuronal Cells
    Silvia Rea, David Della‐Morte, Francesca Pacifici, Barbara Capuani, Donatella Pastore, Andrea Coppola, Roberto Arriga, Aikaterini Andreadi, Giulia Donadel, Nicola Di Daniele et al. · 2020 · Frontiers in Pharmacology
  79. Dopamine induces TNFα and TNF-R1 expression in SH-SY5Y human neuroblastoma cells
    Cristina Gómez-Santos, Roser Francisco, Pol Giménez‐Xavier, Santiago Ambrosio · 2007 · Neuroreport
  80. Dopamine Agonist Pergolide Prevents Levodopa-Induced Quinoprotein Formation in Parkinsonian Striatum and Shows Quenching Effects on Dopamine-Semiquinone Generated in Vitro
    Ikuko Miyazaki, Masato Asanuma, Francisco J. Javier Diaz-Corrales, Ko Miyoshi, Norio Ogawa · 2005 · Clinical Neuropharmacology
  81. Differential effects of the ascorbyl and tocopheryl derivative on the methamphetamine-induced toxic behavior and toxicity
    Shinobu Ito, Tomohisa Mori, Hideko Kanazawa, Toshiko Sawaguchi · 2007 · Toxicology
  82. Diagnosis by simplicity: an aptachip for dopamine capture and accurate detection with a dual colorimetric and fluorometric system
    Tzu‐Yang Lin, Kuo‐Chen Wei, Shin‐Pon Ju, Chiung-Yin Huang, Hung‐Wei Yang · 2018 · Journal of Materials Chemistry B
  83. Effects of biotin deficiency on short term memory: The role of glutamate, glutamic acid, dopamine and protein kinase A
    Mustafa Munzuroğlu, Betül Danışman, Güven Akçay, İhsan Yelli, Mutay Aslan, Narin Derin · 2022 · Brain Research
  84. Semi-Automatic Signature-Based Segmentation Method for Quantification of Neuromelanin in Substantia Nigra
    Gašper Zupan, Dušan Šuput, Zvezdan Pirtošek, Andrej Vovk · 2019 · Brain Sciences
  85. Sex and intrauterine growth restriction modify brain neurotransmitters profile of newborn piglets
    Marta Vázquez-Gómez, Daniel Valent, Consolación García-Contreras, Laura Arroyo, Cristina Óvilo, Beatriz Isabel, Anna Bassols, Antonio Gonzalez‐Bulnes · 2016 · International Journal of Developmental Neuroscience
  86. Neurotoxic regimens of methamphetamine induce persistent expression of phospho‐c‐Jun in somatosensory cortex and substantia nigra
    Steven J. O’Dell, John F. Marshall · 2004 · Synapse
  87. Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons
    Yijuan Du, You Bin Lee, Steven M. Graves · 2021 · Neuropharmacology
  88. A novel tyrosine hyperoxidation enables selective peptide cleavage
    Shengping Zhang, Luis M. De Leon Rodriguez, Freda F. Li, Renjie Huang, Ivanhoe K. H. Leung, Paul W. R. Harris, Margaret Anne Brimble · 2022 · Chemical Science
  89. Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity
    Meghan L. Bucher, Amy R. Dunn, Joshua M. Bradner, Kristen Stout Egerton, James P. Burkett, Michelle A. Johnson, Gary Wright Miller · 2024 · European Journal of Neuroscience
  90. Electrochemical biosensors for the assay of DNA damage initiated by ferric ions catalyzed oxidation of dopamine in room temperature ionic liquid
    Miaomiao Chen, Huayu Xiong, Wei Wen, Xun Zhang, Haoshuang Gu, Shengfu Wang · 2013 · Electrochimica Acta
  91. Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity
    Mika Takeshima, Maiko Murata, Natsuho Urasoe, Shinki Murakami, Ikuko Miyazaki, Masato Asanuma, Taizo Kita · 2011 · Neurological Research
  92. Selective and Sensitive OECT Sensors with Doped MIP-Modified GCE/MWCNT Gate Electrodes for Real-Time Detection of Serotonin
    Amin Mehrehjedy, Jack Eaton, Kan Tang, Saroj Upreti, Aries Sanders, Vincent LaRoux, Xiaodan Gu, Xuyang He, Song Guo · 2025 · ACS Omega
  93. Molecular mechanisms and treatment strategies for methamphetamine‑induced neurodegeneration, inflammation and neurotoxicity
    Samareh Omidvari, Zahra Azimzadeh, Fariborz Rashnoo, Foozhan Tahmasebinia, Aliasghar Keramatinia, Navid Ahmady Roozbahany, Hojjat‐Allah Abbaszadeh, Shahram Darabi · 2023 · Acta Neurobiologiae Experimentalis
  94. Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology
    Fatema Currim, Reeya Tanwar, Josephine M. Brown-Leung, Neha Paranjape, Jennifer Liu, Laurie H. Sanders, Jonathan A. Doorn, Jason R. Cannon · 2024 · NeuroToxicology
  95. Ectopic deposition of melanin pigments as detoxifying mechanism: a paradigm for basal nuclei pigmentation
    Federico De Marco, Cesira Foppoli, Raffaella Coccia, Carla Blarzino, Marzia Perluigi A, Chiara Cini, Maria Luisa Marcante · 2004 · Biochemical and Biophysical Research Communications
  96. Hypoxia, Acidification and Inflammation: Partners in Crime in Parkinson’s Disease Pathogenesis?
    Johannes Burtscher, Grégoire Paul Millet · 2021 · Immuno
  97. Carving the senescent phenotype by the chemical reactivity of catecholamines: An integrative review
    Aleksei G. Golubev · 2022 · Ageing Research Reviews
  98. Dorsal Motor Nucleus of Vagus protein aggregates in Lewy Body Disease with autonomic dysfunction
    Veronica M. Miller, Rose Anne Kenny, Arthur Ernest Oakley, Ros Hall, Raj N. Kalaria, Louise M. Allan · 2009 · Brain Research
  99. Complicated function of dopamine in Aβ-related neurotoxicity: Dual interactions with Tyr10 and SNK(26–28) of Aβ
    Mengmeng Liu, Lu Kou, Yannan Bin, Liping Wan, Juan Xiang · 2016 · Journal of Inorganic Biochemistry
  100. Huntington's disease: The mystery unfolds?
    Åsa Petersén, Patrik Brundin · 2002 · International review of neurobiology